Crushed Versus Integral Tablets of Ticagrelor in ST-Segment Elevation Myocardial Infarction Patients: A Randomized Pharmacokinetic/Pharmacodynamic Study

被引:64
作者
Alexopoulos, Dimitrios [1 ]
Barampoutis, Nikolaos [1 ]
Gkizas, Vasileios [1 ]
Vogiatzi, Chrysoula [1 ]
Tsigkas, Grigorios [1 ]
Koutsogiannis, Nikolaos [1 ]
Davlouros, Periklis [1 ]
Hahalis, George [1 ]
Nylander, Sven [2 ]
Parodi, Guido [3 ]
Xanthopoulou, Ioanna [1 ]
机构
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
[2] AstraZeneca R&D, Molndal, Sweden
[3] Careggi Hosp, Cardiovasc & Thorac Dept, Florence, Italy
关键词
PREHOSPITAL TICAGRELOR; ANTIPLATELET ACTION; RAPID ACTIVITY; PRASUGREL; INHIBITION; ONSET; PHARMACOKINETICS; PHARMACODYNAMICS; CLOPIDOGREL; CANGRELOR;
D O I
10.1007/s40262-015-0320-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective The objective of this study was to assess the pharmacokinetic and pharmacodynamic behavior of ticagrelor administered either as crushed (in the semi-upright sitting position) or as integral (in the supine position) tablets in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). Methods We randomized 20 patients to ticagrelor 180 mg either as 2 integral tablets administered in the supine position (standard administration) or as 2 tablets crushed and dispersed, administered in the semi-upright sitting position. Blood samples were drawn for pharmacokinetic and pharmacodynamic assessment at randomization (0 h) and at 0.5, 1, 2, and 4 h. Results At 1 h, ticagrelor plasma exposure and area under the plasma concentration-time curve from time zero to 1 h (AUC(1)) (co-primary endpoints) were higher in the crushed versus integral tablets group (median 586 vs. 70.1 ng/mL and 234 vs. 24.4 ng.h/mL, respectively), with a ratio of adjusted geometric means (95 % confidence interval [CI]) of 12.67 (2.34-68.51) [p = 0.005] and 19.28 (3.51-106.06) [p = 0.002], respectively. Time to maximum plasma concentration was shorter in the crushed versus integral tablets group (median 2 vs. 4 h), with a ratio of adjusted geometric means (95 % CI) of 0.69 (0.49-0.97) [p = 0.035]. Parallel findings were observed with AR-C124910XX (active metabolite). Platelet reactivity (VerifyNow (R)) at 1 h was lower with crushed versus standard administration with least squares estimates mean difference (95 % CI) of 92 (-158.4 to 26.6) P2Y(12) reaction units (p = 0.009). Conclusions In patients with STEMI undergoing primary PCI, ticagrelor crushed tablets administered in the semi-upright sitting position seems to lead to a faster-compared with standard administration-absorption, with stronger antiplatelet activity within the first hour.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 26 条
[1]   Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist [J].
Akers, Wendell S. ;
Oh, Jennifer J. ;
Oestreich, Julie H. ;
Ferraris, Suellen ;
Wethington, Mary ;
Steinhubl, Steven R. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (01) :27-35
[2]   Effects of P2Y12 Receptor Inhibition in Patients With ST-Segment Elevation Myocardial Infarction [J].
Alexopoulos, Dimitrios ;
Xanthopoulou, Ioanna ;
Goudevenos, John .
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (12) :2064-2069
[3]   Onset of Antiplatelet Action With High (100 mg) Versus Standard (60 mg) Loading Dose of Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Pharmacodynamic Study [J].
Alexopoulos, Dimitrios ;
Makris, George ;
Xanthopoulou, Ioanna ;
Patsilinakos, Sotirios ;
Deftereos, Spyridon ;
Gkizas, Vassilios ;
Perperis, Angelos ;
Karanikas, Stavros ;
Angelidis, Christos ;
Tsigkas, Grigorios ;
Koutsogiannis, Nikolaos ;
Hahalis, George ;
Davlouros, Periklis .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (02) :233-+
[4]   Double Versus Standard Loading Dose of Ticagrelor Onset of Antiplatelet Action in Patients With STEMI Undergoing Primary PCI [J].
Alexopoulos, Dimitrios ;
Gkizas, Vassilios ;
Patsilinakos, Sotirios ;
Xanthopoulou, Ioanna ;
Angelidis, Christos ;
Anthopoulos, Prodromos ;
Makris, George ;
Perperis, Angelos ;
Karanikas, Stavros ;
Koutsogiannis, Nikolaos ;
Davlouros, Periklis ;
Deftereos, Spyridon ;
Chiladakis, John ;
Hahalis, George .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (10) :940-941
[5]   Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment-Elevation Myocardial Infarction [J].
Alexopoulos, Dimitrios ;
Xanthopoulou, Ioanna ;
Gkizas, Vassilios ;
Kassimis, George ;
Theodoropoulos, Konstantinos C. ;
Makris, George ;
Koutsogiannis, Nikolaos ;
Damelou, Anastasia ;
Tsigkas, Grigorios ;
Davlouros, Periklis ;
Hahalis, George .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (06) :797-804
[6]  
[Anonymous], ORAL CRUSHED DISPERS
[7]   Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events [J].
Bhatt, Deepak L. ;
Stone, Gregg W. ;
Mahaffey, Kenneth W. ;
Gibson, C. Michael ;
Steg, P. Gabriel ;
Hamm, Christian W. ;
Price, Matthew J. ;
Leonardi, Sergio ;
Gallup, Dianne ;
Bramucci, Ezio ;
Radke, Peter W. ;
Widimsky, Petr ;
Tousek, Frantisek ;
Tauth, Jeffrey ;
Spriggs, Douglas ;
McLaurin, Brent T. ;
Angiolillo, Dominick J. ;
Genereux, Philippe ;
Liu, Tiepu ;
Prats, Jayne ;
Todd, Meredith ;
Skerjanec, Simona ;
White, Harvey D. ;
Harrington, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14) :1303-1313
[8]   Evaluation of crushed ticagrelor tablet doses: Recovery following crushing and naso-gastric tube passage ex vivo [J].
Crean B. ;
Finnie C. ;
Crosby A. .
Drugs in R&D, 2013, 13 (2) :153-157
[9]   Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study [J].
Gurbel, Paul A. ;
Bliden, Kevin P. ;
Butler, Kathleen ;
Tantry, Udaya S. ;
Gesheff, Tania ;
Wei, Cheryl ;
Teng, Renli ;
Antonino, Mark J. ;
Patil, Shankar B. ;
Karunakaran, Arun ;
Kereiakes, Dean J. ;
Parris, Cordel ;
Purdy, Drew ;
Wilson, Vance ;
Ledley, Gary S. ;
Storey, Robert F. .
CIRCULATION, 2009, 120 (25) :2577-U103
[10]   Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction [J].
Heestermans, Antonius A. C. M. ;
van Werkum, Jochem W. ;
Taubert, Dirk ;
Seesing, Toine H. ;
von Beckerath, Nicolas ;
Hackeng, Christian M. ;
Schomig, Edgar ;
Verheugt, F. W. A. ;
ten Berg, Jurrien M. .
THROMBOSIS RESEARCH, 2008, 122 (06) :776-781